CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Activation of the adenosine receptor A2AR is associated with suppression of T cell function in the tumor microenvironment. To overcome immunosuppression, here the authors show that CRISPR/Cas9 mediated deletion of A2AR enhances CAR T cell effector functions without altering memory or persistence pro...
Main Authors: | Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, Junyun Lai, Amanda X. Y. Chen, Deborah Meyran, Kirsten L. Todd, Emma V. Petley, Sherly Mardiana, Christina Mølck, Gregory D. Stewart, Benjamin J. Solomon, Ian A. Parish, Paul J. Neeson, Simon J. Harrison, Lev M. Kats, Imran G. House, Phillip K. Darcy, Paul A. Beavis |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-23331-5 |
Similar Items
-
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
by: Kevin Sek, et al.
Published: (2018-12-01) -
Switching on the green light for chimeric antigen receptor T‐cell therapy
by: Sherly Mardiana, et al.
Published: (2019-01-01) -
126 Early-phenotype Lewis Y CAR-T cells persist better in vivo and induce solid tumor regression in combination with anti-PD1
by: Deborah Meyran, et al.
Published: (2020-11-01) -
CAR T cells take centre stage
by: Paul A Beavis, et al.
Published: (2019-01-01) -
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
by: Sherly Mardiana, et al.
Published: (2020-05-01)